IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 250 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.84 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $123,316 | +13.5% | 12,713 | +21.5% | 0.00% | – |
| Q2 2023 | $108,679 | -1.2% | 10,460 | 0.0% | 0.00% | – |
| Q1 2023 | $110,039 | -15.1% | 10,460 | 0.0% | 0.00% | – |
| Q4 2022 | $129,600 | -75.1% | 10,460 | -77.1% | 0.00% | -100.0% |
| Q4 2020 | $520,000 | -38.7% | 45,622 | -51.6% | 0.00% | -50.0% |
| Q3 2020 | $848,000 | +12.9% | 94,316 | +29.6% | 0.00% | 0.0% |
| Q2 2020 | $751,000 | +1.8% | 72,766 | -0.5% | 0.00% | 0.0% |
| Q1 2020 | $738,000 | +1.7% | 73,110 | +34.0% | 0.00% | 0.0% |
| Q4 2019 | $726,000 | -35.5% | 54,540 | -40.3% | 0.00% | -66.7% |
| Q1 2014 | $1,125,000 | +121.9% | 91,322 | +109.0% | 0.01% | +100.0% |
| Q4 2013 | $507,000 | -1.9% | 43,685 | 0.0% | 0.00% | 0.0% |
| Q3 2013 | $517,000 | +19.7% | 43,685 | +0.5% | 0.00% | +50.0% |
| Q2 2013 | $432,000 | – | 43,486 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 1,520,000 | $19,562,000 | 18.54% |
| Sarissa Capital Management LP | 16,390,000 | $210,939,000 | 16.77% |
| Healthcare Value Capital, LLC | 200,000 | $2,574,000 | 5.13% |
| Camber Capital Management LP | 7,500,000 | $96,525,000 | 3.25% |
| 13D Management LLC | 650,455 | $8,371,000 | 2.88% |
| BRIDGER MANAGEMENT, LLC | 2,035,114 | $26,192,000 | 2.44% |
| Brown Capital Management | 18,484,759 | $237,899,000 | 1.80% |
| Healthcare Value Capital, LLC | 50,000 | $644,000 | 1.28% |
| Zebra Capital Management LLC | 53,359 | $687,000 | 0.80% |
| PRICE MICHAEL F | 520,000 | $6,692,000 | 0.74% |